Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure

Background: Acute decompensated heart failure (ADHF) is a life-threatening condition with a high mortality rate. Levosimendan is an effective inotropic agent used to maintain cardiac output and a long-lasting effect. However, only few studies have compared the clinical outcomes, after levosimendan t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wei-Chieh, Wu, Po-Jui, Fang, Hsiu-Yu, Fang, Yen-Nan, Chen, Huang-Chung, Tong, Meng-Shen, Sung, Pei-Hsun, Lee, Chieh-Ho, Chung, Wen-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322737/
https://www.ncbi.nlm.nih.gov/pubmed/35887759
http://dx.doi.org/10.3390/jcm11143997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322737/
https://www.ncbi.nlm.nih.gov/pubmed/35887759
http://dx.doi.org/10.3390/jcm11143997

Ejemplares similares